Represent

Lobbying
Lobbying by Parkinson's Action Network

Lobbying Relationship

Client

Parkinson's Action Network

More records

Lobbying firm

PARKINSON'S ACTION NETWORK

More records

"The Senate Innovations Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections;
"H.R. 775/S. 539, Medicare Access to Rehabilitation Services Act," all sections;"H.R. 3081/S.1778, The TELE-Med Act, all sections;"H.R. 2624/S. 1488, The Part D Beneficiary Fairness Appeals Act," all sections; "The Veterans E-Health and Telemedicine Support Act," (S. 2170); Medicare support for FDA breakthrough therapies (coalition sign-on support letter)
"H.R. 263, Adult Day Center Enhancement Act," all sections; and "S. 1549, The Care Planning Act of 2015," all sections.
"S.697, Frank R. Lautenberg Chemical Safety for the 21st Century Act," all sections.

Duration: January 1, 2008 to April 29, 2016

General Issues: Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Family Issues/Abortion/Adoption, Environmental/Superfund, Health Issues, Science/Technology, Taxation/Internal Revenue Code, Veterans, Budget/Appropriations

Spending: about $341,796 (But it's complicated. Here's why.)

Agencies lobbied since 2008: U.S. Senate, House of Representatives, House of Representatives,, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Treasury - Dept of, Labor - Dept of (DOL), U.S. Senate,, White House Office, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), President of the U.S.,, Office of Science & Technology Policy (OSTP)

Bills mentioned

H.R.292: Advancing Research for Neurological Diseases Act of 2015

Sponsor: Michael C. Burgess (R-Texas)

S.849: Advancing Research for Neurological Diseases Act of 2016

Sponsor: Johnny Isakson (R-Ga.)

H.R.775: Medicare Access to Rehabilitation Services Act of 2015

Sponsor: Charles Boustany Jr. (R-La.)

S.539: Medicare Access to Rehabilitation Services Act of 2015

Sponsor: Benjamin L. Cardin (D-Md.)

H.R.3081: TELE-MED Act of 2015

Sponsor: Devin Nunes (R-Calif.)

S.1778: TELE-MED Act of 2015

Sponsor: Mazie K. Hirono (D-Hawaii)

H.R.2624: Part D Beneficiary Appeals Fairness Act

Sponsor: Hank Johnson (D-Ga.)

S.1488: Part D Beneficiary Appeals Fairness Act

Sponsor: Bill Nelson (D-Fla.)

S.2170: VETS Act of 2015

Sponsor: Joni Ernst (R-Iowa)

H.R.263: Adult Day Center Enhancement Act

Sponsor: Barbara Lee (D-Calif.)

S.1549: Care Planning Act of 2015

Sponsor: Mark Warner (D-Va.)

S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act

Sponsor: Tom Udall (D-N.M.)

H.R.2029: Consolidated Appropriations Act, 2016

Sponsor: Charlie Dent (R-Pa.)

H.R.2: Medicare Access and CHIP Reauthorization Act of 2015

Sponsor: Michael C. Burgess (R-Texas)

S.RES.145: A resolution supporting the designation of April 2015, as "Parkinson's...

Sponsor: Debbie Stabenow (D-Mich.)

S.2866: In-Home CARE Act

Sponsor: Cory Booker (D-N.J.)

H.R.713: Medicare Access to Rehabilitation Services Act of 2013

Sponsor: Jim Gerlach (R-Pa.)

S.367: Medicare Access to Rehabilitation Services Act of 2013

Sponsor: Benjamin L. Cardin (D-Md.)

H.R.5580: Accelerating Biomedical Research Act

Sponsor: Rosa DeLauro (D-Conn.)

H.R.647: ABLE Act of 2014

Sponsor: Ander Crenshaw (R-Fla.)

S.313: ABLE Act of 2013

Sponsor: Bob Casey (D-Pa.)

H.R.2001: VETS Act of 2013

Sponsor: Charles B. Rangel (D-N.Y.)

S.2738: Toxic Exposure Research Act of 2014

Sponsor: Richard Blumenthal (D-Conn.)

H.R.4892: Military and Veteran Caregiver Services Improvement Act of 2014

Sponsor: Jim Langevin (D-R.I.)

S.2243: Military and Veteran Caregiver Services Improvement Act of 2014

Sponsor: Patty Murray (D-Wash.)

H.R.3077: TELE-MED Act of 2013

Sponsor: Devin Nunes (R-Calif.)

H.R.5380: Medicare Telehealth Parity Act of 2014

Sponsor: Mike Thompson (D-Calif.)

H.R.4683: Lifespan Respite Care Reauthorization Act of 2014

Sponsor: Jim Langevin (D-R.I.)

S.2115: American Cures Act

Sponsor: Richard J. Durbin (D-Ill.)

H.R.4384: America HEALS Act

Sponsor: Anna G. Eshoo (D-Calif.)

S.2126: Regenerative Medicine Promotion Act of 2014

Sponsor: Barbara Boxer (D-Calif.)

S.2110: Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014

Sponsor: Ron Wyden (D-Ore.)

H.R.4015: SGR Repeal and Medicare Provider Payment Modernization Act of 2014

Sponsor: Michael C. Burgess (R-Texas)

S.RES.408: A resolution supporting the designation of April as "Parkinson's...

Sponsor: Debbie Stabenow (D-Mich.)

H.R.2725: Food and Drug Administration Safety Over Sequestration Act of 2013

Sponsor: Leonard Lance (R-N.J.)

S.1413: FDA User Fee Protection Act

Sponsor: Mark Pryor (D-Ark.)

H.R.2810: SGR Repeal and Medicare Beneficiary Access Act of 2013

Sponsor: Michael C. Burgess (R-Texas)

S.1871: SGR Repeal and Medicare Beneficiary Access Act of 2013

Sponsor: Max Baucus (D-Mont.)

H.R.2775: Continuing Appropriations Act, 2014

Sponsor: Diane Black (R-Tenn.)

S.RES.118: A resolution supporting the designation of April as Parkinson's...

Sponsor: Debbie Stabenow (D-Mich.)

H.RES.149: Expressing support for designation of April as Parkinson's Awareness Month.

Sponsor: Carolyn B. Maloney (D-N.Y.)

H.R.2595: National Neurological Diseases Surveillance System Act of 2011

Sponsor: Chris Van Hollen (D-Md.)

S.425: National Neurological Diseases Surveillance System Act of 2011

Sponsor: Mark Udall (D-Colo.)

H.R.3070: Departments of Labor, Health and Human Services, and Education, and...

Sponsor: Denny Rehberg (R-Mont.)

S.3295: Departments of Labor, Health and Human Services, and Education, and...

Sponsor: Tom Harkin (D-Iowa)

H.R.5856: Department of Defense Appropriations Act, 2013

Sponsor: C. W. Bill Young (R-Fla.)

H.R.1546: Medicare Access to Rehabilitation Services Act of 2011

Sponsor: Jim Gerlach (R-Pa.)

S.829: Medicare Access to Rehabilitation Services Act of 2011

Sponsor: Benjamin L. Cardin (D-Md.)

H.R.4132: FAST Act

Sponsor: Cliff Stearns (R-Fla.)

S.2113: TREAT Act

Sponsor: Kay Hagan (D-N.C.)

S.3187: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

H.R.1362: To ensure that members of the Armed Forces continue to receive their pay...

Sponsor: Kevin Yoder (R-Kan.)

H.R.4808: To suspend temporarily the rate of duty on certain programmable slow...

Sponsor: Robert C. Scott (D-Va.)

H.R.2376: Stem Cell Research Advancement Act of 2011

Sponsor: Diana DeGette (D-Colo.)

H.R.1362: National Neurological Diseases Surveillance System Act of 2010

Sponsor: Chris Van Hollen (D-Md.)

S.1273: National MS and Parkinson's Disease Registries Act

Sponsor: Byron L. Dorgan (D-N.D.)

H.R.5732: Part D Off-Label Prescription Parity Act

Sponsor: Mary Jo Kilroy (D-Ohio)

H.R.4808: Stem Cell Research Advancement Act of 2009

Sponsor: Diana DeGette (D-Colo.)

S.3766: Stem Cell Research Advancement Act of 2010

Sponsor: Arlen Specter (D-Pa.)

H.R.1347: ConTACT Act of 2010

Sponsor: Bill Pascrell Jr. (D-N.J.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...

Sponsor: John D. Dingell (D-Mich.)

H.R.4691: Temporary Extension Act of 2010

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4213: Unemployment Compensation Extension Act of 2010

Sponsor: Charles B. Rangel (D-N.Y.)

S.RES.474: A resolution supporting the designation of April as Parkinson's...

Sponsor: Debbie Stabenow (D-Mich.)

H.R.1428: To amend title 38, United States Code, to direct the Secretary of...

Sponsor: Bob Filner (D-Calif.)

H.R.2965: Don't Ask, Don't Tell Repeal Act of 2010

Sponsor: Jason Altmire (D-Pa.)

S.1233: SBIR/STTR Reauthorization Act of 2009

Sponsor: Mary L. Landrieu (D-La.)

H.R.2648: To authorize the President to award a gold medal on behalf of Congress...

Sponsor: André Carson (D-Ind.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

H.R.2569: To reauthorize surface transportation research, development, and...

Sponsor: David Wu (D-Ore.)

S.914: Cures Acceleration Network and National Institutes of Health...

Sponsor: Arlen Specter (D-Pa.)

H.R.1: American Recovery and Reinvestment Act of 2009

Sponsor: David R. Obey (D-Wis.)

H.R.1105: Omnibus Appropriations Act, 2009

Sponsor: David R. Obey (D-Wis.)

H.R.873: Stem Cell Research Enhancement Act of 2009

Sponsor: Diana DeGette (D-Colo.)

S.487: Stem Cell Research Enhancement Act of 2009

Sponsor: Tom Harkin (D-Iowa)

H.R.1260: Patent Reform Act of 2009

Sponsor: John Conyers Jr. (D-Mich.)

S.610: Patent Reform Act of 2009

Sponsor: Jon Kyl (R-Ariz.)

S.5: Stem Cell Research Enhancement Act of 2007

Sponsor: Harry Reid (D-Nev.)

H.R.3: Stem Cell Research Enhancement Act of 2007

Sponsor: Diana DeGette (D-Colo.)

H.R.5874: National MS Disease Registry Act

Sponsor: Michael C. Burgess (R-Texas)

S.3230: Departments of Labor, Health and Human Services, and Education, and...

Sponsor: Tom Harkin (D-Iowa)

S.3289: Agriculture, Rural Development, Food and Drug Administration, and...

Sponsor: Herb Kohl (D-Wis.)

H.R.5819: SBIR/STTR Reauthorization Act

Sponsor: Nydia M. Velázquez (D-N.Y.)

H.R.2638: Consolidated Security, Disaster Assistance, and Continuing...

Sponsor: David E. Price (D-N.C.)

H.R.6331: Medicare Improvements for Patients and Providers Act of 2008

Sponsor: Charles B. Rangel (D-N.Y.)

S.1693: Wired for Health Care Quality Act

Sponsor: Edward M. Kennedy (D-Mass.)

H.R.493: Genetic Information Nondiscrimination Act of 2008

Sponsor: Louise M. Slaughter (D-N.Y.)

H.R.2642: Supplemental Appropriations Act, 2008

Sponsor: Chet Edwards (D-Texas)

S.2931: Medicare Access to Complex Rehabilitative and Assistive Technology Act...

Sponsor: Olympia J. Snowe (R-Maine)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist	Covered positions?
Catherine Pugh	n/a
Rebecca O'Connor	n/a
Jennifer Sheridan	n/a
Francesca Fierro O'Reilly	n/a
CHRISTY M. HAHN	n/a
JOAN I. SAMUELSON	n/a
MARY MCGUIRE-RICHARDS	n/a
James Tucker	n/a
Jennifer Palute	n/a
Jamie Tucker	n/a
Timothy Johnson	n/a
John Schall	n/a
John Hunter	n/a
Mary Richards	n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

0th Quarter, 2004

Registration

2nd Quarter, 2016

Termination

1st Quarter, 2016

Amendment

PARKINSON'S ACTION NETWORK amended a lobbying report for in-house lobbying in Q12016 on April 20, 2017 Original Filing: 300873484.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2016

Q1 Report

In Q1, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on July 11, 2016. Original Filing: 300807822.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2015

Q4 Report

In Q4, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Jan. 19, 2016. Original Filing: 300776278.xml

Lobbying Issues

"FY 2016 Labor, Health and Human Services, Education, and Related Agencies Appropriations," sections relating to the National Institutes of Health (NIH); "FY 2016 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations," all sections relating to the Food and Drug Administration; "FY 2016 Department of Defense Appropriations," all sections related to the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "The Senate Innovations Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections; Consolidated Omnibus Appropriations Act of 2015 (H.R. 2029)

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2015

Q3 Report

In Q3, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Oct. 13, 2015. Original Filing: 300752382.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2015

Q2 Report

In Q2, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on July 20, 2015. Original Filing: 300743983.xml

Lobbying Issues

"FY 2016 Labor, Health and Human Services, Education, and Related Agencies Appropriations," sections relating to the National Institutes of Health (NIH); "FY 2016 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations," all sections relating to the Food and Drug Administration; "FY 2016 Department of Defense Appropriations," all sections related to the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "The 21st Century Cures Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections; and the "FY 2016 National Defense Authorization Act," related to McCain Amendment SA 1482, to prohibit funding for certain medical research at the Department of Defense.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2015

Q1 Report

In Q1, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on April 20, 2015. Original Filing: 300721651.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2014

Q4 Report

In Q4, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Jan. 20, 2015. Original Filing: 300701642.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2014

Q3 Report

In Q3, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Oct. 20, 2014. Original Filing: 300684296.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2014

Q2 Report

In Q2, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on July 21, 2014. Original Filing: 300666395.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2014

Q1 Report

In Q1, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on April 21, 2014. Original Filing: 300644107.xml

Lobbying Issues

"FY 2014 Labor, Health and Human Services, Education, and Related Agencies Approprations," sections relating to the National Institutes of Health (NIH) and the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative; "FY 2014 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations," all sections relating to the Food and Drug Administration; "FY 2014 Department of Defense Appropriations," all sections relating to the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; P.L. 112-25, "Budget Control Act of 2011," all sections relating to sequestration; Bipartisan Budget Act of 2013 (P.L. 113-67), funding for medical research; "FY 2015 Labor, Health and Human Services, Education, and Related Agencies Approprations," sections relating to the National Institutes of Health (NIH) and the National Institute of Neurological Disorders and Stroke; "FY 2015 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations," all sections relating to the Food and Drug Administration; "FY 2015 Department of Defense Appropriations," all sections relating to the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; American Cures Act (S. 2115); "America HEALS Act" (H.R. 4384); A resolution supporting the designation of April as "Parkinson's Awareness Month" (S.RES. 408)

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2013

Q4 Report

In Q4, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Jan. 17, 2014. Original Filing: 300617654.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2013

Q3 Report

In Q3, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Oct. 18, 2013. Original Filing: 300600122.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2013

Q2 Report

In Q2, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on July 22, 2013. Original Filing: 300581190.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2013

Q1 Report

In Q1, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on April 22, 2013. Original Filing: 300561052.xml

Lobbying Issues

P.L. 112-25, "Budget Control Act of 2011," all sections relating to sequestration; P.L 113-006, "Consolidated and Further Continuing Appropriations Act, 2013," sections relating to the National Institutes of Health (NIH); Food and Drug Administration, and the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program;"Fiscal Year 2014 Department of Labor, Health and Human Services, Education and Related Agencies Appropriations," all sections relating to the National Institutes of Health (NIH); "Fiscal Year 2014 Department of Defense Appropriations,"all sections relating to the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Fiscal Year 2014 Department of Agriculture, Rural Development, Food and Drug Adminstration, and Related Agencies Appropriations," all sections relating to the Food and Drug Administration.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2012

Q4 Report

In Q4, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Jan. 22, 2013. Original Filing: 300540269.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2012

Registration

3rd Quarter, 2012

Termination

PARKINSON'S ACTION NETWORK in-house lobbying effort was terminated on Oct. 19, 2012 Original Filing: 300514358.xml

Lobbying Issues

H.R. 2595/S. 425, "The National Neurological Diseases Surveillance System Act," all sections; H.R. 3070/S. 3295, "Department of Labor, Health and Human Services, Education and Related Agencies Appropriations," all sections relating to the National Institutes of Health (NIH); H.R. 5856 "Department of Defense Appropriations," all sections relating to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 1546/S. 829, "The Medicare Access to Rehabilitation Services Act of 2011," all sections; P.L. 111-148, "Patient Protection and Affordable Care Act," all sections relating to state exchanges and Essential Health Benefits; P.L. 112-25, "Budget Control Act of 2011," all sections relating to sequestration; and proposed legislation relating to the use of telemedicine under Medicare and other Federal health care programs.

Agencies Lobbied

Type of Issue

2nd Quarter, 2012

Q2 Report

In Q2, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on July 20, 2012. Original Filing: 300496334.xml

Lobbying Issues

H.R. 2595/S.425, "The National Neurological Diseases Surveillance System Act" all sections; "Department of Labor, Health and Human Services, Education and Related Agencies Appropriations," all sections relating to the National Institutes of Health (NIH); "Department of Defense Appropriations," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 1546/S.829, "The Medicare Access to Rehabilitation Services Act of 2011" all sections; H.R. 4132, "The Faster Access to Specialized Treatments Act of 2011" all sections; S. 2113 "The Transforming the Regulatory Environment to Accelerate Access to Treatment of 2011" all sections; S. 3187 "The Food and Drug Administration Safety and Innovation Act" all sections;

Agencies Lobbied

Type of Issue

1st Quarter, 2012

Q1 Report

In Q1, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on April 20, 2012. Original Filing: 300472455.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2011

Q4 Report

In Q4, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Jan. 20, 2012. Original Filing: 300447284.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2011

Q3 Report

In Q3, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Oct. 18, 2011. Original Filing: 300417205.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2011

Q2 Report

In Q2, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on July 20, 2011. Original Filing: 300403264.xml

Lobbying Issues

H.R.XX (introduced 7/20/11- no bill # yet)/S. 425, "The National Neurological Diseases Surveillance System Act," all sections; " all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, the National Center for Advancing Translational Sciences" "Department of Defense Appropriations," sec. related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R 2376 Stem Cell Research Advancement Act of 2011 all sections; CMS Plan Year 2012 Draft Call Letter forMedicare Part D; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2012," all sections related to FDA; Prescription Drug User Fee Act (PDUFA) V (not yet related to specific legislation); H.R.1546/S.829, "the Medicare Access to Rehabiltational Services Act of 2011", all sections.

Agencies Lobbied

Type of Issue

1st Quarter, 2011

Amendment

PARKINSON'S ACTION NETWORK amended a lobbying report for in-house lobbying in Q12011 on Oct. 13, 2011 Original Filing: 300413367.xml

Lobbying Issues

H.R. 1362 & S. 425, "The National Neurological Diseases Surveillance System Act," all sections; " all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell ResearchAdvancement Act of 2010; creation of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health; Fiscal Year 2012 funding for the NIH Institute on Aging; Senate resolution designating April as Parkinsons Awareness Month.

Agencies Lobbied

Type of Issue

1st Quarter, 2011

Q1 Report

In Q1, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on April 20, 2011. Original Filing: 300374967.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2010

Q4 Report

In Q4, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Jan. 20, 2011. Original Filing: 300353161.xml

Lobbying Issues

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

Agencies Lobbied

Type of Issue

3rd Quarter, 2010

Q3 Report

In Q3, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Oct. 20, 2010. Original Filing: 300327944.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2010

Q2 Report

In Q2, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on July 20, 2010. Original Filing: 300298938.xml

Lobbying Issues

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the NIH, Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and a new review divison for Biochemical and Genetic Diseases within the Center for Drug Evaluation Research, Office of New Drugs at FDA; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; "Energy and Water Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; "Interior, Environment, and Related Agencies Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; H.R 4808, "Stem Cell Research Enhancement Act of 2009," all sections; and legislation relating to the extension of the Medicare Part B therapy cap exceptions process.

Agencies Lobbied

Type of Issue

1st Quarter, 2010

Q1 Report

In Q1, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on April 20, 2010. Original Filing: 300272388.xml

Lobbying Issues

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," section 10409 relating to Cures Acceleration Network, sections relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, section relating to Medicare Part B therapy cap exceptions process,sections relating to Medicaid eligibility levels; H.R. 3962, "Affordable Health Care for America Act," section relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, sections relating to Medicaid eligibility levels, section relating to Medicare Part B therapy cap exceptions process; H.R. 4691, "Temporary Extension Act of 2010," section relating to Medicare Part B therapy cap exceptions process; H.R. 4213, "Tax Extenders Act of 2009," section relating to Medicare Part B therapy cap exceptions process; S.Res. 474, "A resolution supporting the designation of April as Parkinson's Awareness Month;" Medical Device Approval at the Food and Drug Administration.

Agencies Lobbied

Type of Issue

4th Quarter, 2009

Q4 Report

In Q4, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Jan. 20, 2010. Original Filing: 300246817.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2009

Q3 Report

In Q3, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Oct. 20, 2009. Original Filing: 300214718.xml

Lobbying Issues

HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; H.R. 2965, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S. 1233, "SBIR/STTR Reauthorization Act of 2009," section 108 regarding Majority-Venture Investments in SBIR Firms and all sections relating to the National Institutes of Health; H.R. 2648, "To authorize the President to award a gold medal on behalf of Congress to Muhammad Ali in recognition of his contributions to the Nation"; Senate Finance Committee "America's Healthy Future Act of 2009," section relating to Therapeutic Discovery Project Tax Credit and regarding modifying Medicare's physician payment formula to encouragehigherquality, lowercostcareforMedicarebeneficiarieswithsevereordisablingchronicconditions; H.R. 3200, "America's Affordable Health Choices Act of 2009," regarding modifying Medicare's physician payment formula to encouragehigherquality, lowercostcareforMedicarebeneficiarieswithsevereordisablingchronicconditions; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).

Agencies Lobbied

Type of Issue

2nd Quarter, 2009

Q2 Report

In Q2, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on July 20, 2009. Original Filing: 300191114.xml

Lobbying Issues

HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; HR 2569, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S 914, "Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009," all sections; "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010," all sections related to the National Institutes of Health; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to FDA; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).

Agencies Lobbied

Type of Issue

1st Quarter, 2009

Q1 Report

In Q1, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on April 20, 2009. Original Filing: 300162965.xml

Lobbying Issues

HR 1362, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1, "The American Recovery and Reinvestment Act, 2009," all sections relating to the National Institutes of Health; HR 1105, "The Omnibus Appropriations Act, 2009," sections relating to the National Institutes of Health and the Food and Drug Administration;HR 873/S 487, "Stem Cell Research Enhancement Act of 2009," all sections; HR 1260/S 610, "Patent Reform Act of 2009," sections related to diagnostic and therapeutic product development; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to the Food and Drug Administration.

Agencies Lobbied

Type of Issue

4th Quarter, 2008

Q4 Report

In Q4, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Jan. 21, 2009. Original Filing: 300132370.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2008

Q3 Report

In Q3, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on Oct. 17, 2008. Original Filing: 300099271.xml

Lobbying Issues

H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA; H.R.2638 "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009," all sections related to the National Institutes of Health, section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program, all sections related to FDA; H.R. 6331, S. 1693 "The Wired for Health Care Quality Act," all sections related to health information technology.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2008

Q2 Report

In Q2, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on July 23, 2008. Original Filing: 300084215.xml

Lobbying Issues

H.R. 493, "Genetic Information Nondiscrimination Act," all sections. H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. H.R. 2642 the "Consolodated Supplemental Appropriations Act, 2008," all sections related to National Institutes of Health and the Food and Drug Administration."Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA;

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2008

Q1 Report

In Q1, PARKINSON'S ACTION NETWORK had in-house lobbyists. The report was filed on April 21, 2008. Original Filing: 300054301.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Legislators

Bills

Statements

Lobbying

Travel

Lobbyists

Disclosures Filed